We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

Share Price Information for CATCo (CAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 13.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 22.00 (169.231%)
Open: 24.00
High: 24.00
Low: 24.00
Prev. Close: 24.00
CAT Live PriceLast checked at -
CATCo Reinsurance Opportunities is an Investment Trust

To provide investors with significant capital returns and long-term distributions by making investments linked to catastrophe reinsurance risks via a variety of insurance-based investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Scheme of arrangement - Update

10 Dec 2021 07:00

RNS Number : 2069V
CATCo Reinsurance Opps Fund Ltd
10 December 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

 

 

Markel CATCo Announces Update Regarding Proposed Schemes of Markel CATCo Reinsurance Fund Ltd. and CATCo Reinsurance Opportunities Fund Ltd.

 

London, 10 December 2021. Further to its previous announcements regarding the Buy-Out Transaction, Markel CATCo Investment Management Ltd (provisional liquidators appointed for restructuring purposes) announces that the convening hearing in respect of the schemes of arrangement proposed by Markel CATCo Reinsurance Fund Ltd. (provisional liquidators appointed for restructuring purposes) and CATCo Reinsurance Opportunities Fund Ltd. (provisional liquidators appointed for restructuring purposes) concluded Wednesday. The Court is considering the arguments. The Court has not fixed a date for delivery of judgment, however it is anticipated that it will likely not be delivered until January 2022. Further updates will be provided as soon as further information becomes available.

Details of the Buy-Out Transaction and the proposed schemes of arrangement are available on the Scheme Website at https://catcobuyout.alixpartners.com.

The person responsible for arranging release of this announcement is: Mark Way, Chief of Investor Marketing, Markel CATCo Investment Management Ltd.

 

 

Disclaimers and important notices

This announcement is for information purposes only and is not intended to, and does not, constitute or form part of any offer or invitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Buy-Out Transaction or otherwise. The Schemes will be made solely pursuant to the terms of the scheme documents to be sent to investors in Markel CATCo Reinsurance Fund Ltd. (provisional liquidators appointed for restructuring purposes) (the Private Fund) and CATCo Reinsurance Opportunities Fund Ltd. (provisional liquidators appointed for restructuring purposes) (the Public Fund, and together with the Private Fund, the Funds) in due course. The scheme documents will contain the full terms and conditions of the Schemes, including details of how to vote in respect of them. Any decision in respect of, or other response to, the Schemes should be made only on the basis of the information in those documents. The information contained in this announcement is for background purposes only and no reliance may or should be placed by any person for any purpose whatsoever on the information contained in this announcement or on its completeness, accuracy or fairness. Recipients of this announcement should conduct their own investigation, evaluation and analysis of the business, data and property described in this announcement. This announcement does not constitute a recommendation concerning any investor's decision or options with respect to the Buy-Out Transaction. The information in this announcement is subject to change.

 

The distribution of this announcement and the terms of the Buy-Out Transaction are subject to restrictions and may not be made except pursuant to registration with or authorisation by the relevant securities regulatory authorities or an exemption therefrom. Therefore, persons who may come into possession of this announcement are advised to consult with their own legal advisors as to what restrictions may be applicable to them and to observe such restrictions. This announcement may not be used for the purpose of an offer or invitation in any circumstances in which such offer or invitation is not authorised.

 

No action has been or will be taken in any jurisdiction by the Funds that would or is intended to permit a public offering, or any other offering under circumstances not permitted by applicable law, of any securities.

 

Further to the above, the release, publication or distribution of this announcement in other jurisdictions may be restricted by law and therefore any persons who are subject to the laws of any applicable jurisdiction (including any jurisdiction where local laws or regulations may result in a significant risk of civil, regulatory or criminal exposure if information concerning the Buy-Out Transaction is sent or made available to investors in that jurisdiction (Restricted Jurisdictions)) should inform themselves about, and observe, any applicable legal or regulatory requirements. In particular, the ability of persons who are resident in such other jurisdictions or who are subject to the laws of another jurisdiction to participate in the Buy-Out Transaction may be affected by the laws of the relevant jurisdictions in which they are located or to which they are subject. Any failure to comply with applicable legal or regulatory requirements of any jurisdiction may constitute a violation of securities laws in that jurisdiction.

 

Copies of this announcement and any formal documentation relating to the Buy-Out Transaction are not being, and must not be, directly or indirectly, mailed or otherwise forwarded, distributed or sent in or into or from any Restricted Jurisdiction or any jurisdiction where to do so would constitute a violation of the laws of such jurisdiction and persons receiving such documents (including custodians, nominees and trustees) must not mail or otherwise forward, distribute or send them in or into or from any Restricted Jurisdiction. Doing so may render invalid any related purported vote in respect of the Buy-Out Transaction (or the related Schemes).

 

Certain of the statements in this announcement or (and any related oral statements) may be considered forward-looking statements.

 

This announcement (including information incorporated by reference in this announcement), oral statements made regarding the Buy-Out Transaction, information accessed through https://catcobuyout.alixpartners.com and other information published by MCIM and the Funds contain statements which are, or may be deemed to be, "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995.

 

Forward-looking statements are prospective in nature and are not based on historical facts, but rather on current expectations and projections of the management of MCIM and the Funds about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. The forward-looking statements contained in this announcement include statements relating to the expected effects of the Buy-Out Transaction, the expected timing and scope of the Buy-Out Transaction and other statements other than historical facts. Often, but not always, forward-looking statements can be identified by the use of forward-looking words such as "plans", "expects" or "does not expect", "is expected", "is subject to", "budget", "projects", "strategy", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. Although MCIM and the Funds believe that the expectations reflected in such forward-looking statements are reasonable, they can give no assurance that such expectations will prove to be correct. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future.

 

There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements. These factors include, but are not limited to: the ability to complete the Buy-Out Transaction; the ability to obtain requisite regulatory and other required approvals and the satisfaction of other conditions on the proposed terms and schedule; and/or the anticipated benefits from the proposed transaction not being realised as a result of changes in general economic and market conditions in the countries in which the Funds operate, owing to weak, volatile or illiquid capital and/or credit markets, changes in tax rates, interest rate and currency value fluctuations, the degree of competition in the geographic and business areas in which the Funds operate and changes in laws or in supervisory expectations or requirements.

 

Other unknown or unpredictable factors could cause actual results to differ materially from those in the forward-looking statements. Such forward-looking statements should therefore be construed in the light of such factors. Neither MCIM nor the Funds, nor any of their respective associates or directors, officers or advisers, provides any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements in this announcement will actually occur. You are cautioned not to place any reliance on these forward-looking statements. Other than in accordance with their legal or regulatory obligations, neither MCIM nor the Funds is under any obligation, and they expressly disclaim any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. This announcement speaks only as of the date issued.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SOATLBJTMTIMTMB
Date   Source Headline
24th Apr 20247:00 amRNSFinal Results
23rd Feb 20247:00 amRNSNet Asset Value(s)
23rd Nov 20237:00 amRNSNet Asset Value(s)
26th Sep 20237:00 amRNSHalf-year Report
29th Aug 20237:00 amRNSNet Asset Value(s)
7th Jun 20232:00 pmRNSResult of AGM
17th May 20237:00 amRNSNet Asset Value(s)
26th Apr 20237:00 amRNSFinal Results
16th Feb 20237:00 amRNSNet Asset Value(s)
2nd Dec 20227:00 amRNSHolding(s) in Company
30th Nov 20227:00 amRNSCompulsory Acqn of Shares
21st Nov 202211:42 amRNSCompulsory Acqn of Shares - correction
21st Nov 20227:00 amRNSCompulsory Acqn of Shares
2nd Nov 20227:00 amRNSNet Asset Value(s)
11th Oct 20222:00 pmRNSPrice Monitoring Extension
14th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20227:00 amRNSNet Asset Value(s)
11th Aug 20227:00 amRNSNet Asset Value(s) and Portfolio Update
2nd Aug 202210:38 amRNSHolding(s) in Company
22nd Jul 20227:00 amRNSNet Asset Value(s)
14th Jul 20227:00 amRNSNet Asset Value Reporting Change
12th Jul 20227:00 amRNSNet Asset Value(s)
7th Jun 20227:00 amRNSNet Asset Value(s)
1st Jun 20222:00 pmRNSResult of AGM
3rd May 202212:04 pmRNSDirectorate Change
28th Apr 20227:00 amRNSFinal Results
20th Apr 20224:25 pmRNSHolding(s) in Company
19th Apr 20221:44 pmRNSHolding(s) in Company
13th Apr 20224:41 pmRNSHolding(s) in Company
13th Apr 20222:48 pmRNSHolding(s) in Company
13th Apr 20222:46 pmRNSHolding(s) in Company
7th Apr 20227:00 amRNSPartial Compulsory Redemption of Shares
29th Mar 20227:00 amRNSScheme of arrangement - Closing Date
17th Mar 20227:00 amRNSScheme of arrangement - U.S. Bankruptcy Court
11th Mar 20224:46 pmRNSScheme of arrangement - Sanction of Schemes
10th Mar 20227:00 amRNSSOA - Chairperson’s Report on Scheme Meetings
7th Mar 20227:00 amRNSNet Asset Value(s)
7th Mar 20227:00 amRNSScheme of arrangement -Sanction Hearing & Timeline
28th Feb 20227:00 amRNSScheme of arrangement - Voting deadline 1 March
24th Feb 20227:00 amRNSScheme of arrangement - US Bankruptcy Court
18th Feb 20223:04 pmRNSScheme of arrangement - Notices of Scheme Meetings
17th Feb 20227:00 amRNSScheme of arrangement - Convening Order
14th Feb 20225:31 pmRNSScheme of arrangement - Directions Hearing
11th Feb 20227:00 amRNSScheme of arrangement - Amendment of Undertakings
7th Feb 20227:00 amRNSNet Asset Value(s)
4th Feb 20227:00 amRNSScheme of arrangement - improved terms
23rd Dec 20217:00 amRNSNet Asset Value(s)
13th Dec 20212:00 pmRNSScheme of arrangement - Update
10th Dec 20217:00 amRNSScheme of arrangement - Update
18th Nov 20211:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.